TALPHERA, INC. Debt Instrument, Convertible, Number of Equity Instruments
TALPHERA, INC. (TLPH) reported Debt Instrument, Convertible, Number of Equity Instruments of 2.03 million shares for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments · last filed 2012-11-06
- TALPHERA, INC. debt instrument, convertible, number of equity instruments for the quarter ending 2012-09-30 was 0.00 shares.
| Period end | Debt Instrument, Convertible, Number of Equity Instruments 3 month | Debt Instrument, Convertible, Number of Equity Instruments 6 month | Debt Instrument, Convertible, Number of Equity Instruments 9 month |
|---|---|---|---|
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | 2.03M shares 10-Q · filed 2012-11-06 | |
| 2012-06-30 | 2.03M shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |